Highlights in Non-Small Cell Lung Cancer From ASCO 2020 Highlights in Non-Small Cell Lung Cancer From ASCO 2020
Dr Mark Kris reports on key studies in NSCLC from ASCO 2020, including the practice-changing ADAURA trial, results on an antibody-drug conjugate targeting HER2, and data on a new checkpoint inhibitor.Medscape
Source: Medscape Today Headlines - Category: Consumer Health News Tags: None ReCAP Source Type: news
More News: Cancer | Cancer & Oncology | Health | HER2 | Lung Cancer | Non-Small Cell Lung Cancer | Study